Choroby układu krążenia— wyzwanie dla biotechnologii
Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS
The significance of thromboembolic complications in the etiology and development of cardiovascular diseases, such as ischaemic heart disease or myocardial infarction, is undisputableand well documented. It is commonly believed that intravascular thrombi may cause vesselnarrowing and even lead to complete vessel occulsion. When encountering circulation, narrowingof vascular lumen, such as intravascular clots and platelet aggregates, is believed to result inthromboembolisms. Activation of the fibrinolytie system allows for the proteolysis of fibrin clots,the main components of vascular thrombi, and thus it may lead to vascular reperfusion.
Biotechnologia, vol.44, 1 (1999)-.
0860-7796 ; oai:rcin.org.pl:143447 ; IChB B-40
Library of Institute of Bioorganic Chemistry PAS
Creative Commons Attribution BY-SA 4.0 license
Institute of Bioorganic Chemistry of the Polish Academy of Science
Institute of Bioorganic Chemistry of the Polish Academy of Science
Nov 18, 2020
Oct 19, 2020
306
https://rcin.org.pl/publication/178636
Edition name | Date |
---|---|
Choroby układu krążenia— wyzwanie dla biotechnologii | Nov 18, 2020 |
Sławińska, Anna Siwek, Maria
Tyczewska, Agata Bąkowska- Żywicka, Kamila
Pieczyński, Marcin Bielewicz, Dawid Dolata, Jakub Szweykowska-Kulińska, Zofia
Broniarczyk, Justyna Koczorowska, Maria Magdalena Durzyńska, Julia Warowicka, Alicja Goździcka-Józefiak, Anna